INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$196K
362 sh
Sep 9, 2026
Page 130 of 532
← PrevNext →

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUY
Sep 11, 2026
traded Sep 9, 2026
+2d
SEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$415K
761 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$116K
215 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$212K
396 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$196K
368 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$652K
1,202 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$69K
131 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$371K
687 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$837K
1,539 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$87K
160 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$7,996
23 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$9,145
25 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$104K
1,493 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$117K
218 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$86K
160 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$199K
368 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$57K
106 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
2,679 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$66K
120 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

0
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$32K
60 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

0
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$15K
335 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

51
JS
Jubran SamiEVP Chief Finance Officer
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$55K
1,824 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

48
JS
Jubran SamiEVP Chief Finance Officer
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$36K
1,196 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

46
GP
Gu PaulDirector, Chief Executive Officer
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$1.28M
50.0K sh
Sep 10, 2026Sep 10, 2026
traded Sep 10, 2026
+0dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.08M
29.9K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

42
SA
Senn AndrewPresident, Growth & Innovation
ITGRInteger Holdings Corp
Open-market sale
SELL$1.19M
9,408 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

42
BS
Butcher StephanieSenior Managing Director
IVZInvesco Ltd.
Open-market sale
SELL$1.46M
45.1K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

42
WH
Williams Ashley HDirector
TFSLTFS Financial CORP
Open-market sale
SELL$173K
10.0K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

42
MJ
Morais Silvio JoseDirector
STNEStoneCo Ltd.
Open-market sale
SELL$208K
21.0K sh
Sep 2, 2026Sep 10, 2026
traded Sep 2, 2026
+8dSEC Form 4

Evidence

42
PJ
Parish Douglas J.Director
BWBBridgewater Bancshares Inc
Open-market sale
SELL$86K
4,000 sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

41
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$567K
5,468 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.14M
11.3K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

40
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.93M
41.6K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

40
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.23M
55.9K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.11M
21.1K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

39
CF
Chang Hung-Lun (Fred)*** See Remarks
AAOIAPPLIED OPTOELECTRONICS, INC.
Open-market sale
SELL$3.55M
32.2K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

38
LP
Lynch Thomas P.See Remarks
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
2,518 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

38
AA
Attal AlainDirector
GMEGameStop Corp.
Open-market purchase
BUY$100K
5,000 sh
Sep 10, 2026Sep 10, 2026
traded Sep 10, 2026
+0dSEC Form 4

Evidence

38
BC
Baker Jeffery CDirector
ATLOAMES NATIONAL CORP
Open-market purchase
BUY$9,564
300 sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

37
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$1.49M
42.4K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

UPBDUPBOUND GROUP, INC.Nov 2 – Nov 3
7 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  • SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K